View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . November 2nd, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Aerie Pharmaceuticals - Aerie Pharmaceuticals' ROCK Inhibitor, AR-12286, Demonstrates Positive Results in Glaucoma Patients in a Phase 2a Study

Breast Cancer - Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer

Celgene Corporation - Celgene Reports Record Third Quarter 2009 Operating and Financial Results

Small Cell Lung Cancer - Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals

Atrial Fibrillation - New atrial fibrillation data have been reported by D.J. Ellis and co-authors

Breast Cancer - New breast cancer study findings recently were published by researchers at University of Freiburg

Cancer - New data from Chang-Gung University illuminate research in cancer

Cancer - Reports outline cancer study results from P.O. Witteveen et al

Cancer - Research from Kyorin University, Medical Department in cancer provides new insights

Cancer - Study data from A. Dowlati and co-authors update knowledge of cancer

Chemotherapy - Research results from E. Hernandez and co-authors update knowledge of chemotherapy

Conjunctivitis - Findings in conjunctivitis reported from J.S. Pelletier and co-researchers

Esophageal Cancer - Studies from T. Ruhstaller et al further understanding of esophageal cancer

Gastric Cancer - Researchers at Chonnam National University have published new data on gastric cancer

Gastrointestinal Stromal Tumors - New gastrointestinal stromal tumors findings from G.D. Demetri and co-researchers published

Graft-Versus-Host Disease - Findings from University of Freiburg broaden understanding of graft-versus-host disease

Headache and Migraine - Reports outline headache and migraine study results from K.M. Connor et al

Hematology - Findings in hematology reported from M. Schiff and co-researchers

Hepatocellular Cancer - Research from Ohio State University in hepatocellular cancer provides new insights

HIV/AIDS - Researchers from Johns Hopkins University, Medical Department report recent findings in HIV/AIDS

Lupus - Studies from D.J. Wallace et al further understanding of lupus

Monoclonal Antibodies - Report summarizes monoclonal antibodies study findings from B. Neyns and co-researchers

Myelodysplastic Syndrome - Researchers from Stanford University publish findings in myelodysplastic syndrome

Osteosarcoma - New osteosarcoma research from S.P. Chawla and co-researchers described

Pharmacokinetics - Research on pharmacokinetics reported by scientists at GlaxoSmithKline

Pharmacokinetics - Studies from C.C. Lin et al further understanding of pharmacokinetics

Simian Immunodeficiency Virus - Studies from Kyushu University add new findings in the area of simian immunodeficiency virus

Solid Cancer - Findings from N. Yamamoto and co-authors provide new insights into solid cancer

Thyroid Cancer - Scientists at University of California target thyroid cancer

Acute Lymphoblastic Leukemia Therapy - Researchers from Catholic University of Korea describe findings in acute lymphoblastic leukemia therapy

Cancer Therapy - New cancer therapy study findings reported from University of South Florida

Life Sciences - Reports from Martin-Luther University highlight recent research in life sciences

Life Sciences - Study results from School of Veterinary Medicine, Department of Animal Health in the area of life sciences published

Mantle Cell Lymphoma Therapy - New mantle cell lymphoma therapy research from University of Texas, M.D. Anderson Cancer Center described

Monoclonal Antibodies - New monoclonal antibodies findings from S. Orsola-Malpighi Hospital, Department of Medical Oncology described

Prostate Cancer - Research on prostate cancer reported by scientists at Lund University, Department of Urology

Solid Cancer Clinical Trial - Researchers' work from Royal Marsden Hospital, Department of Radiology focuses on solid cancer clinical trial

Alzheimer Disease - AFFiRiS AG - Encouraging Results From Phase I Studies of two Alzheimer's Candidate Vaccines Trigger a EUR 10 Million Milestone Payment

Amarin Corporation plc - Amarin Appoints Medpace as CRO for Two Phase 3 Cardiovascular Trials

Argos Therapeutics - Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference

Arthritis - New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

Biogen Idec - Biogen Idec and Biovitrum Announce Decision to Advance Long-Acting Hemophilia B Therapy into a Registrational Trial

Biogen Idec Inc. - Biogen Idec Extends Offer to Acquire Facet Biotech Corporation for $14.50 Per Share in Cash

Biotechnology - Pulmo BioTech Inc. Announces Further Details of its Previously Announced Letter of Intent Intended to Bring its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) to the European Market

Cancer Vaccines - Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain

Celgene Corporation - Updated Data from Randomized Controlled Phase II Study Evaluating Oral Apremilast in Psoriatic Arthritis Demonstrates Sustained Response at Six Months

Central Nervous System Disease - Medivation Names Hank Mansbach, M.D., Vice President of Medical Affairs

Central Nervous System Disorders - BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman

Cystic Fibrosis - Transave Completes Successful Phase II Clinical Program for ARIKACE in the Treatment of Pseudomonas Lung Infections

Diabetes - MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in Treatment of Diabetic Macular Edema

Diabetic Neuropathy - Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting

Elan Corporation, plc and Biogen Idec - Elan to Highlight Tysabri Data in Crohn's Disease at the American College of Gastroenterology Annual Scientific Meeting

Emisphere Technologies, Inc. - Study Results: Novel Oral PTH Formulation Using Emisphere's Eligen(R) Technology Showed Potential Therapeutical Advantages to Available Injectable PTH in Postmenopausal Osteoporotic Women

Endocyte Inc. - Endocyte Presents Data on EC145 in Treatment of Ovarian Cancer Before the European Society of Gynaecologic Oncology

Fusion Proteins - ArmaGen Technologies Selects PacificGMP to Manufacture Its Fusion Protein for Phase 1 Clinical Trial

Genzyme Corp. - Genzyme Reports Third-Quarter Financial Results

Genzyme Corporation - First Patient Enrolled in Phase 3 Trials of Genzyme Oral Capsule for Gaucher Disease

GlycoMimetics, Inc. - GlycoMimetics, Inc. Attracts $38 Million in Latest Venture Round

Halozyme Therapeutics, Inc. - Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin(R)

Human Genome Sciences, Inc. - Human Genome Sciences and GlaxoSmithKline Announce Full Presentation at ACR of Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus

KAI Pharmaceuticals, Inc. - KAI Reports Positive Preclinical Results in Pain Therapeutic Program Targeting Gamma Protein Kinase C PKC Pathway

KemPharm, Inc. - KemPharm, Inc. Announces Initiation of Phase 1 Trial of KP106 for ADHD

Liposuction - AcelRx Announces Positive Results from a Phase 2 Study of ARX-03, a Sufentanil/Triazolam NanoTab for Procedural Sedation, Anxiolysis & Analgesia

Lung Cancer - Biomoda Enters Final Stage of Patient Testing for Phase II Lung Cancer Clinical Study

Millennium: The Takeda Oncology Company - Millennium Initiates Phase II Trial for Diffuse Large B-Cell Lymphoma

Obesity - Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009

Obesity and Diabetes - Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes

Pancreatitis - Repligen Announces Completion of Patient Treatment in Phase 3 Clinical Trial of RG1068 in MRI Imaging of the Pancreas

Pfizer Inc - CP-690,550, Pfizer's Oral JAK Inhibitor, Demonstrates Response Both Alone and In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis

Pharmaceuticals - ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the American College of Clinical Pharmacy (ACCP) 2009 Annual Meeting

Pre-Trials Research - Proteolix to Present Preclinical Data on Carfilzomib and PR-957 at the 2009 ACR/ARHP Annual Meeting

Psoriatic Arthritis - New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Research and Markets Ltd. - Biopharma Quarter: Key Trends and Events of the Second Quarter of 2009

Seattle Genetics, Inc. - Seattle Genetics Highlights Pipeline Progress and Reports Third Quarter 2009 Financial Results

Solid Cancer - FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy

Surgery - Action Pharma in new Phase II Clinical Trial

Thyroid Cancer - Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer

TransMolecular, Inc. - TransMolecular's 131I-TM601 Shown to Improve Survival in Recurrent Malignant Glioma

Type 1 Diabetes - Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At the IDF's 20th World Diabetes Congress

Wellstat Therapeutics Corporation - Wellstat Therapeutics and Sanofi-aventis Enter Agreement On Novel Therapy for Type II Diabetes

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx